Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling

Abstract The monofunctional platinum(II) complex, phenanthriplatin, acts by blocking transcription, but its regulatory effects on long-noncoding RNAs (lncRNAs) have not been elucidated relative to traditional platinum-based chemotherapeutics, e.g., cisplatin. Here, we treated A549 non-small cell lun...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jerry D. Monroe, Satya A. Moolani, Elvin N. Irihamye, Katheryn E. Lett, Michael D. Hebert, Yann Gibert, Michael E. Smith
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/e55824703fa84bb4bb1566c8e9a7f0a8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e55824703fa84bb4bb1566c8e9a7f0a8
record_format	dspace
spelling	oai:doaj.org-article:e55824703fa84bb4bb1566c8e9a7f0a82021-12-02T16:51:31ZCisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling10.1038/s41598-021-89911-z2045-2322https://doaj.org/article/e55824703fa84bb4bb1566c8e9a7f0a82021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89911-zhttps://doaj.org/toc/2045-2322Abstract The monofunctional platinum(II) complex, phenanthriplatin, acts by blocking transcription, but its regulatory effects on long-noncoding RNAs (lncRNAs) have not been elucidated relative to traditional platinum-based chemotherapeutics, e.g., cisplatin. Here, we treated A549 non-small cell lung cancer and IMR90 lung fibroblast cells for 24 h with either cisplatin, phenanthriplatin or a solvent control, and then performed microarray analysis to identify regulated lncRNAs. RNA22 v2 microRNA software was subsequently used to identify microRNAs (miRNAs) that might be suppressed by the most regulated lncRNAs. We found that miR-25-5p, -30a-3p, -138-5p, -149-3p, -185-5p, -378j, -608, -650, -708-5p, -1253, -1254, -4458, and -4516, were predicted to target the cisplatin upregulated lncRNAs, IMMP2L-1, CBR3-1 and ATAD2B-5, and the phenanthriplatin downregulated lncRNAs, AGO2-1, COX7A1-2 and SLC26A3-1. Then, we used qRT-PCR to measure the expression of miR-25-5p, -378j, -4516 (A549) and miR-149-3p, -608, and -4458 (IMR90) to identify distinct signaling effects associated with cisplatin and phenanthriplatin. The signaling pathways associated with these miRNAs suggests that phenanthriplatin may modulate Wnt/β-catenin and TGF-β signaling through the MAPK/ERK and PTEN/AKT pathways differently than cisplatin. Further, as some of these miRNAs may be subject to dissimilar lncRNA targeting in A549 and IMR90 cells, the monofunctional complex may not cause toxicity in normal lung compared to cancer cells by acting through distinct lncRNA and miRNA networks.Jerry D. MonroeSatya A. MoolaniElvin N. IrihamyeKatheryn E. LettMichael D. HebertYann GibertMichael E. SmithNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Jerry D. Monroe Satya A. Moolani Elvin N. Irihamye Katheryn E. Lett Michael D. Hebert Yann Gibert Michael E. Smith Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling
description	Abstract The monofunctional platinum(II) complex, phenanthriplatin, acts by blocking transcription, but its regulatory effects on long-noncoding RNAs (lncRNAs) have not been elucidated relative to traditional platinum-based chemotherapeutics, e.g., cisplatin. Here, we treated A549 non-small cell lung cancer and IMR90 lung fibroblast cells for 24 h with either cisplatin, phenanthriplatin or a solvent control, and then performed microarray analysis to identify regulated lncRNAs. RNA22 v2 microRNA software was subsequently used to identify microRNAs (miRNAs) that might be suppressed by the most regulated lncRNAs. We found that miR-25-5p, -30a-3p, -138-5p, -149-3p, -185-5p, -378j, -608, -650, -708-5p, -1253, -1254, -4458, and -4516, were predicted to target the cisplatin upregulated lncRNAs, IMMP2L-1, CBR3-1 and ATAD2B-5, and the phenanthriplatin downregulated lncRNAs, AGO2-1, COX7A1-2 and SLC26A3-1. Then, we used qRT-PCR to measure the expression of miR-25-5p, -378j, -4516 (A549) and miR-149-3p, -608, and -4458 (IMR90) to identify distinct signaling effects associated with cisplatin and phenanthriplatin. The signaling pathways associated with these miRNAs suggests that phenanthriplatin may modulate Wnt/β-catenin and TGF-β signaling through the MAPK/ERK and PTEN/AKT pathways differently than cisplatin. Further, as some of these miRNAs may be subject to dissimilar lncRNA targeting in A549 and IMR90 cells, the monofunctional complex may not cause toxicity in normal lung compared to cancer cells by acting through distinct lncRNA and miRNA networks.
format	article
author	Jerry D. Monroe Satya A. Moolani Elvin N. Irihamye Katheryn E. Lett Michael D. Hebert Yann Gibert Michael E. Smith
author_facet	Jerry D. Monroe Satya A. Moolani Elvin N. Irihamye Katheryn E. Lett Michael D. Hebert Yann Gibert Michael E. Smith
author_sort	Jerry D. Monroe
title	Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling
title_short	Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling
title_full	Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling
title_fullStr	Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling
title_full_unstemmed	Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling
title_sort	cisplatin and phenanthriplatin modulate long-noncoding rna expression in a549 and imr90 cells revealing regulation of micrornas, wnt/β-catenin and tgf-β signaling
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/e55824703fa84bb4bb1566c8e9a7f0a8
work_keys_str_mv	AT jerrydmonroe cisplatinandphenanthriplatinmodulatelongnoncodingrnaexpressionina549andimr90cellsrevealingregulationofmicrornaswntbcateninandtgfbsignaling AT satyaamoolani cisplatinandphenanthriplatinmodulatelongnoncodingrnaexpressionina549andimr90cellsrevealingregulationofmicrornaswntbcateninandtgfbsignaling AT elvinnirihamye cisplatinandphenanthriplatinmodulatelongnoncodingrnaexpressionina549andimr90cellsrevealingregulationofmicrornaswntbcateninandtgfbsignaling AT katherynelett cisplatinandphenanthriplatinmodulatelongnoncodingrnaexpressionina549andimr90cellsrevealingregulationofmicrornaswntbcateninandtgfbsignaling AT michaeldhebert cisplatinandphenanthriplatinmodulatelongnoncodingrnaexpressionina549andimr90cellsrevealingregulationofmicrornaswntbcateninandtgfbsignaling AT yanngibert cisplatinandphenanthriplatinmodulatelongnoncodingrnaexpressionina549andimr90cellsrevealingregulationofmicrornaswntbcateninandtgfbsignaling AT michaelesmith cisplatinandphenanthriplatinmodulatelongnoncodingrnaexpressionina549andimr90cellsrevealingregulationofmicrornaswntbcateninandtgfbsignaling
_version_	1718382952244576256

Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling

Ejemplares similares